ADIPOQ and diabetic cardiomyopathy: A study by Boursereau and colleagues showed that knockout of adiponectin activated Toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB signaling pathway and induced muscle inflammation by decreasing the expression of miR-711 [15], but little is known about whether miR-711 is regulated by adiponectin in diabetic cardiomyopathy.